4//SEC Filing
Kelley Robert J. 4
Accession 0001209191-21-068753
CIK 0001584751other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:14 PM ET
Size
5.5 KB
Accession
0001209191-21-068753
Insider Transaction Report
Form 4
Kelley Robert J.
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2021-12-08+450,000→ 450,000 totalExercise: $4.28Exp: 2031-12-07→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.
Documents
Issuer
Talis Biomedical Corp
CIK 0001584751
Entity typeother
Related Parties
1- filerCIK 0001845542
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 4:14 PM ET
- Size
- 5.5 KB